SCHEMBL967488

SCHEMBL967488

CC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)[C](F)F

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7782659 1.00 THRB (0.31) THRB
SCHEMBL732983 1.00 THRB (0.31) THRB
SCHEMBL7782664 1.00 THRB (0.31) THRB
SCHEMBL654937 1.00 THRB (0.31) THRB
SCHEMBL7780933 1.00 THRB (0.31) THRB
SCHEMBL1772080 1.00 THRB (0.31) THRB
SCHEMBL7783379 1.00 THRB (0.31) THRB
SCHEMBL967742 1.00 THRB (0.31) THRB
SCHEMBL7783416 1.00 THRB (0.31) THRB
SCHEMBL525838 0.97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 131 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024138977-A1 HYBRID EMULSION AND PREPARATION METHOD THEREFOR 上海华谊三爱富新材料有限公司 2024-07-04 WO claimed
CN-116284581-A Hybrid emulsion and preparation method thereof 上海华谊三爱富新材料有限公司 2023-06-23 CN claimed
EP-2500015-A1 Delivery of drugs Landec Corporation (US) 2012-09-19 EP claimed
EP-2101745-A1 DELIVERY OF DRUGS LANDEC CORPORATION (US) 2009-09-23 EP claimed
US-20080269105-A1 Delivery of drugs ALCON RESEARCH, LLC 2008-10-30 US claimed
WO-2008070118-A9 DRUG DELIVERY LANDEC CORP (US) 2008-09-18 WO claimed
EP-1287047-B1 PHOTO-POLYMERS AND USE THEREOF TERAHERTZ PHOTONICS LTD (GB) 2008-08-13 EP claimed
WO-2008070118-A1 DRUG DELIVERY LANDEC CORPORATION (US) 2008-06-12 WO claimed
US-20060179643-A1 Rechargeable lithium polymer cell and process for the production of rechargeable lithium polymer batteries GAIA AKKUMULATORENWERKE GMBH (DE) 2006-08-17 US claimed
US-20030114619-A1 Photo-polymers and use thereof TERAHERTZ PHOTONICS LIMITED (GB) 2003-06-19 US claimed
EP-1287047-A1 PHOTO-POLYMERS AND USE THEREOF TeraHertz Photonics Limited (GB) 2003-03-05 EP claimed
WO-2001094430-A1 PHOTO-POLYMERS AND USE THEREOF TERAHERTZ PHOTONICS LIMITED (GB) 2001-12-13 WO claimed
WO-2023188609-A1 ANTIFOULING TREATMENT AGENT, ANTIFOULING TREATMENT AGENT STOCK SOLUTION, AND ANTIFOULING TREATMENT METHOD パナソニックIPマネジメント株式会社 2023-10-05 WO disclosed
CN-116284581-A Hybrid emulsion and preparation method thereof 上海华谊三爱富新材料有限公司 2023-06-23 CN disclosed
CN-113543866-B Lubricating oil composition, defoaming method for lubricating oil, and defoaming agent composition 引能仕株式会社 2023-01-31 CN disclosed
CN-115485049-A Defoaming agent and lubricating oil composition 引能仕株式会社 2022-12-16 CN disclosed
EP-0825167-A1 COMPOUNDS AND SURFACTANTS ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) 1998-02-25 EP disclosed
EP-0758563-A1 OLEFIN OLIGOMERIZATION CATALYST AND PROCESS FOR THE PREPARATION OF OLEFIN OLIGOMER USING IT NIPPON OIL COMPANY, LTD. (JP) 1997-02-19 EP disclosed
US-5556821-A Catalyst component for the polymerization of olefins NIPPON OIL COMPANY, LIMITED (JP) 1996-09-17 US disclosed
EP-0587440-A2 Catalyst component for the polymerisation of olefins and process for preparing olefin polymers using same NIPPON OIL COMPANY, LIMITED (JP) 1994-03-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269105-A1 Delivery of drugs ABCB11, ABCB1, LPXN THRB 1811/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.